Severe COVID-19 Complicated by Cerebral Venous Thrombosis in a Newborn Successfully Treated with Remdesivir, Glucocorticoids, and Hyperimmune Plasma
Open Access
- 15 December 2021
- journal article
- case report
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (24), 13201
- https://doi.org/10.3390/ijerph182413201
Abstract
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19) pandemic, affecting all age groups with a wide spectrum of clinical presentation ranging from asymptomatic to severe interstitial pneumonia, hyperinflammation, and death. Children and infants generally show a mild course of the disease, although infants have been observed to have a higher risk of hospitalization and severe outcomes. Here, we report the case of a preterm infant with a severe form of SARS-CoV-2 infection complicated by cerebral venous thrombosis successfully treated with steroids, hyperimmune plasma, and remdesivir.This publication has 22 references indexed in Scilit:
- Remdesivir for the Treatment of Covid-19 — Final ReportThe New England Journal of Medicine, 2020
- Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019JAMA Pediatrics, 2020
- COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort studyThe Lancet Child & Adolescent Health, 2020
- Infant With SARS-CoV-2 Infection Causing Severe Lung Disease Treated With RemdesivirPEDIATRICS, 2020
- Targeting the NO‐cGMP‐PDE5 pathway in COVID‐19 infection. The DEDALO projectAndrology, 2020
- COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talkingVirus Research, 2020
- Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature reviewThrombosis Research, 2020
- Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid reviewEmergencias, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020